Effects of acupuncture for the treatment of endometriosis-related pain: A systematic review and meta-analysis

Xu Y, Yang Xu, Zhao W, Wenli Zhao, Li T, Te Li, Zhao Y, Ye Zhao, Bu H, Huaien Bu, Shilin Song
PloS one · 2017 · vol. 12(10) , pp. e0186616 · doi:10.1371/journal.pone.0186616 · PMID:29077705 · PMC5659600 · W2765125049
review OA: gold CC0 ⤵ 47 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This meta-analysis found that acupuncture reduced endometriosis-related pain and serum CA-125 levels compared to various control interventions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This paper is a systematic review and meta-analysis of randomized controlled trials evaluating acupuncture for endometriosis-related pain, searching multiple databases up to December 2016 and including 10 studies with 589 participants. Across trials, acupuncture reduced pelvic pain intensity versus control groups (mean difference 1.36 on a 0–10 scale) and was associated with higher clinical effective rates (odds ratio 2.07), with peripheral blood CA-125 also increasing relative to controls (MD 5.9). A major limitation noted by the authors is that only one small pilot study used placebo control with blinding, while most trials used medication/herb controls that were difficult or impossible to blind, and all studies had small arm sizes (8–36 participants). This paper is centrally about endometriosis — it synthesizes trial evidence on acupuncture’s efficacy for endometriosis-related pain, including pain outcomes, CA-125, and response rates.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis is a multifactorial, oestrogen-dependent, inflammatory, gynaecological condition that can result in long-lasting visceral pelvic pain and infertility. Acupuncture could be an effective treatment for endometriosis and may relieve pain. Our aim in the present study was to determine the effectiveness of acupuncture as a treatment for endometriosis-related pain. METHODS: In December 2016, six databases were searched for randomised controlled trials that determined the effectiveness of acupuncture in the treatment of endometriosis-related pain. Ultimately, 10 studies involving 589 patients were included. The main outcomes assessed were variation in pain level, variation in peripheral blood CA-125 level, and clinical effective rate. All analyses were performed using comprehensive meta-analysis statistical software. RESULTS: Of the 10 studies included, only one pilot study used a placebo control and assessed blinding; the rest used various controls (medications and herbs), which were impossible to blind. The sample sizes were small in all studies, ranging from 8 to 36 patients per arm. The mean difference (MD) in pain reduction (pre- minus post-interventional pain level-measured on a 0-10-point scale) between the acupuncture and control groups was 1.36 (95% confidence intervals [CI] = 1.01-1.72, P<0.0001). Acupuncture had a positive effect on peripheral blood CA-125 levels, as compared with the control groups (MD = 5.9, 95% CI = 1.56-10.25, P = 0.008). Similarly, the effect of acupuncture on clinical effective rate was positive, as compared with the control groups (odds ratio = 2.07; 95% CI = 1.24-3.44, P = 0.005). CONCLUSIONS: Few randomised, blinded clinical trials have addressed the efficacy of acupuncture in treating endometriosis-related pain. Nonetheless, the current literature suggests that acupuncture reduces pain and serum CA-125 levels, regardless of the control intervention used. To confirm these findings, additional, blinded studies with proper controls and adequate sample sizes are needed.
Full text 18,569 characters · extracted from pmc-nxml · 5 sections · click to expand

Intro

Endometriosis is a chronic, oestrogen-dependent, inflammatory disease that affects 5%–15% of reproductive-age women, causing infertility and pain—specifically chronic pelvic pain, deep dyspareunia, dysmenorrhoea, dyschezia, and dysuria [ 1 – 4 ]. It may be that endometriosis-related changes are caused by plastic changes in the peripheral and central nervous systems, and such changes may in fact predispose for other long-lasting pain conditions [ 5 ]. Therefore, it is important that researchers develop strategies to alleviate pain. Current pain therapies often involve various pharmacological and surgical treatments, and the symptoms of endometriosis are frequently treated using oestrogen–gestagen combinations or gonadotropin-releasing hormone (GnRH) agonists that block the menstrual cycle. However, many such interventions do not sufficiently affect perceived pain, and pain relapses are possible [ 6 – 8 ]. Furthermore, they can have considerable side effects, such as menopausal disorders, that represent an additional handicap for affected women [ 9 ]. Thus, acupuncture may serve as a complement or alternative to these treatments. The pain-alleviating effects of acupuncture have been attributed to various physiological and psychological processes, such as activation of endogenous descending pain inhibitory systems, deactivation of brain areas that transmit pain-related signals, interaction between nociceptive impulses and somato-visceral reflexes, and the expectation of symptom relief [ 10 – 12 ]. Cancer antigen 125 (CA-125), a well-established marker of epithelial cell ovarian cancer, is derived from coelomic epithelia, including those of the endometrium, fallopian tubes, ovaries, and peritoneum [ 13 ]. In endometriosis, CA-125 levels are elevated through stimulation of coelomic epithelia [ 14 ]. In previous studies, we have found a strong association between preoperatively elevated CA-125 levels and advanced stage of disease [ 15 ]. Similarly, Amaral et al. reported that women with more advanced degrees of endometriosis showed higher CA-125 levels in both serum and peritoneal fluid [ 16 ]. However, many studies have reported that acupuncture can reduce the level of serum CA-125, relieving the pelvic cavity pain that is associated with endometriosis [ 17 – 20 ] The purpose of this systematic review and meta-analysis was to determine the effectiveness of acupuncture in treating endometriosis-related pain.

Results

A flow chart of the included and excluded studies is shown in Fig 1 . Database searches yielded 46 studies from PubMed, 10 from the Cochrane Central Register of Clinical Trials, 36 from Embase, 50 from CNKI, 48 from Wanfang Data, 32 from VIP, and 41 from CBM. After removal of duplicate records, 112 studies remained. Following the first review, which was based on the title, 16 studies remained, the abstracts of which were reviewed using pre-defined eligibility criteria. A total of 16 studies were then selected for full text review and data processing. During this phase, six studies were excluded. Ultimately, 10 studies, comprising 589 participants, were included in the final meta-analysis. The included studies comprised a total of 295 patients whose endometriosis-related pain was treated using acupuncture. A further 294 patients comprised the control group; the details of their treatment are given below. In the 10 RCTs included, the patients’ age at enrolment ranged from 13 to 52 years. The interventions were all acupuncture, while the control interventions were placebo [ 25 ] (also called sham acupuncture), Western medicine [ 17 , 19 – 20 , 26 ], and Traditional Chinese Medicine [ 18 , 27 – 30 ] ( Table 1 ). One RCT was conducted in Boston, while the others were from China. Other details of this kind are summarised in Table 2 . The quality assessment is summarised in Figs 2 and 3 . Six trials compared the variation in main pain level between acupuncture and control groups. Analysis of the pooled data using a fixed-effects model showed that acupuncture had a positive effect on the primary pain level, as compared with the control groups (MD = 1.36, 95% CI = 1.01–1.72, P < 0.0001; Fig 4 ). Four trials compared the variation in peripheral blood CA-125 levels between acupuncture and control groups. Analysis of the pooled data using a fixed-effects model showed that acupuncture had a positive effect on the peripheral blood CA-125 level, as compared with the control groups (MD = 5.9, 95% CI = 1.56–10.25, P = 0.008; Fig 5 ). Seven trials compared the clinical effective rate of treatment between acupuncture and control groups. Analysis of the pooled data using a fixed-effect model showed that acupuncture had a positive effect on the clinical effective rate, as compared with the control groups (OR = 2.07, 95% CI = 1.24–3.44, P = 0.005; Fig 6 ). Using a funnel plot, the research team analysed publication bias in all included studies ( Fig 7 ). The outcome suggested that there was little publication bias. Six studies failed to meet our inclusion criteria for the following results: (1) in one RCT comparing acupuncture with drug therapy (danazol), the pain conditions were not solely related to endometriosis [ 31 ]; (2) one study involved surgical intervention rather than acupuncture [ 32 ]; (3) one study evaluated the effectiveness of moxibustion alone and point injection, rather than moxibustion as an adjunctive therapy to acupuncture [ 33 ]; (4) four studies compared different methods of acupuncture and lacked a placebo or biomedical group [ 34 – 36 ].

Conclusions

Acupuncture can alleviate the pain of dysmenorrhoea and reduce peripheral blood CA-125. As a result, the therapy could be applied as a complementary treatment for endometriosis-related pain. However, few randomised, blinded clinical trials have addressed the efficacy of acupuncture in treating endometriosis-related pain. Nonetheless, the current literature consistently finds that acupuncture yields better reductions in pain and serum CA-125 levels than do control treatments, regardless of the control intervention used. To confirm this finding, additional studies with proper controls, blinding methods, and adequate sample sizes are needed.

Materials|Methods

We adopted the Cochrane Menstrual Disorders and Subfertility Group (MDSG) search strategy. Reports that described (or might have described) randomised controlled trials of acupuncture in the treatment of endometriosis were obtained using the following strategy: The MDSG specialised register of controlled trials was searched for any trials with endometriosis in the title, abstract, or keyword sections. The following electronic databases were searched (from inception to December 2016): Cochrane Central Register of Controlled Trials (CENTRAL; The Cochrane Library), PubMed, and EMBASE. Four electronic Chinese databases were examined (from inception to December 2016): the Chinese Science and Technology Journal Full-text Database (CNKI), Wanfang Data, the Chinese Biomedical Literature Database (VIP), and the China Biology Medicine (CBM) disc. A detailed search strategy is given in S1 Appendix . We searched the bibliographies of the retrieved studies, narrative reviews, and meta-analyses to identify further relevant articles. Moreover, we contacted the authors to ask for the raw data. An additional search of conference abstracts was carried out on the ISI Web of Knowledge. We included randomised controlled trials (RCTs). We recruited women of reproductive age who had a laparoscopically confirmed diagnosis of endometriosis. The exclusion criteria for individual participants were primary dysmenorrhoea (in the absence of an identifiable pathological condition) and asymptomatic endometriosis. Intervention groups comprised patients who had received acupuncture therapy; control groups had received sham acupuncture, Western medicine, or Traditional Chinese Medicine. Our primary treatment outcome measurement was any change in the level of pelvic pain not associated with menses or sexual activity. This outcome was assessed after 8 weeks of treatment and was based on the pain intensity question in the Endometriosis Symptom Severity Scale [ 21 ]. Using a numerical analogue scale, patients were asked to rate, from 0 to 10, pain severity during the previous 4 weeks that was not associated with menses or sexual activity. The Endometriosis Symptom Severity Scale has been validated and is sensitive to changes in endometriosis-associated pelvic pain in adults (not adolescents) enrolled in clinical trials [ 21 ]. Blood CA-125 levels were determined before and after treatment using an enzyme-linked immunosorbent assay. The overall effectiveness of acupuncture therapy was assessed subjectively and in a dichotomous manner; it was defined as the proportion of participants who experienced relief of their endometriosis-associated pain after acupuncture treatment, as indicated by the patients’ responses to the evaluation criteria. Therapeutic effects were assessed in terms of the diagnosis and treatment standards for Combined Traditional Chinese and Western medicine in the treatment of endometriosis (1991) [ 22 ]. Patients were classified in one of four groups: (1) cured—the symptoms of dysmenorrhoea, abdominal discomfort, abdominal pain, periodic rectal irritation, etc., as well as the pelvic mass, had disappeared; (2) markedly effective—abdominal pain was obviously relieved, other symptoms had improved, and the pelvic mass had narrowed by more than 50%; (3) effective—abdominal pain was relieved, other symptoms had improved, the pelvic mass had narrowed more than 33%, and dysmenorrhoea had not increased in severity three menstrual cycles after treatment; (4) failed—abdominal pain and other symptoms had not changed. The clinical effective rate was calculated using the following equation: (number of cured + markedly effective + effective cases)/ (total number of cases). Searches were conducted and the data were extracted by two independent researchers. Each trial identified in the search was evaluated in terms of design, eligibility criteria for participants, and outcome measures. When the researchers disagreed regarding the eligibility of a trial, they consulted a third researcher to resolve the situation. We created a form for data extraction which included (1) basic information about each trial, including the topic, first author, dateline, and journal; (2) basic information about the patients, including the number of patients in each group and their mean age; (3) the study design and intervention; and (4) the outcomes. The quality of the trials included in this study was assessed by two other researchers in accordance with the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0) [ 23 ]. All analyses were performed using comprehensive meta-analysis statistical software (RevMan 5.1.0; Cochrane Collaboration, Copenhagen, Denmark) [ 23 ]. Continuous outcome variables were analysed using a standardised measure; dichotomous variables were compared and the results were presented as odds ratios (ORs). To obtain the standard deviation (SD) of the change from baseline in the experimental intervention groups, we used the following equation, in which R 1 = 0.5 [ 23 ]: S D ( C ) = S D ( B ) 2 + S D ( F ) 2 − ( 2 × R 1 × S D ( B ) × S D ( F ) The term “ SD(B) ” represents the standard deviation before intervention, while “ SD(F) ” denotes the standard deviation after intervention. We evaluated homogeneity among the trials using I 2 statistics. Specifically, if I 2 was ≥ 50%, the trials were considered heterogeneous, and a random-effects model based on a Mantel–Haenszel (MH) or inverse variance (IV) statistical approach was selected. If I 2 was < 50%, the studies were considered homogeneous, and a fixed-effects model based on an MH or IV statistical approach was used. Pooled summary statistics of the differences in ratio or mean of the individual studies were developed. Pooled differences in ratios or means, as well as two-sided P-values, were calculated and used as criteria for determining the level of statistical significance. P-values < 0.05 were considered statistically significant. Moreover, a sensitivity analysis was conducted based on the “leave-one-out” cross-validation procedure [ 24 ].

Supplementary Material

(DOCX) Click here for additional data file. (DOCX) Click here for additional data file.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Acupuncture Endometriosis Pain Management Endometriosis Female Humans Pain Management Pain Measurement Publication Bias

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Cited by (47)

Source provenance

europepmc
last seen: 2026-07-31T06:09:14.520117+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:13.663096+00:00
License: CC0 · commercial use OK